NanoPalm was founded to solve a persistent challenge in modern medicine — inefficient drug delivery. We combine AI-powered design and patterned nanoparticle engineering to support partners from early evaluation through clinical readiness.
Transform conventional pharma by engineering chips to power drugs enabling more precise, effective, and accessible therapeutics.
A multidisciplinary team spanning nanomedicine, chemistry, computer vision, software engineering, finance, and business development.
PhD in nanomedicine. Expert in nano-drug delivery and gene therapy, driving NanoPalm's global vision and partnerships.
in
PhD in chemistry. Principal investigator driving EnsaliX platform development and pLNP formulation science.
in
MBA in finance. Director of Albilad Capital Internal Audit and Audit Committee Secretary.
in
Founder of TechMENA. Background in economics, engineering, and venture finance. Member at Portfolia.
in
MBA-qualified biotechnology and business development leader with 12+ years of experience in healthcare, biotech partnerships, technology commercialization, and strategic alliances.
in
MSc in Nanoscience and Nanotechnology, specializing in nano-drug delivery systems.
in
PhD in computer engineering. Specializes in computer vision and medical image analysis for EnsaliX.
in
BSc in Science. Experience in pharmaceuticals, sales, and biotech business development.
in
BSc in software engineering. Full-stack development and computer networks supporting EnsaliX.
inNanoPalm is embedded in leading global biotech ecosystems through strategic incubators, conferences, and a growing network of co-development partners.
Join a multidisciplinary team working at the intersection of AI, nanotechnology, drug delivery, and advanced therapeutics.
Join Us →